Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINE-CA: Finerenone After AF Ablation
NCT07799519Phase 2Recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of finerenone in Atrial fibrillation (AFib), sponsored by National Cheng Kung University Hospital. Started Jun 2026; status: recruiting.
02
Drugs
finerenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07799519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07799519.